Finance

Lists
ANRO:NYSE
Alto Neuroscience Inc
US$25,03
-1,11%
(-0,28) 1D
2 āš•.āšĨ., 10 āŧ‚āšĄāš‡ 33 āš™āšēāš—āšĩ 48 āš§āšīāš™āšēāš—āšĩ GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ANRO...
Open
US$25,64
High
US$26,10
Low
US$24,80
Mkt. cap
982,23 āšĨāŧ‰āšēāš™
Avg. vol.
555,72Â āšžāšąāš™
Volume
29,61Â āšžāšąāš™
52-wk high
US$37,48
52-wk low
US$4,71
EPS
US$-2,44
Shares outstanding
39,24 āšĨāŧ‰āšēāš™
No. of employees
68
Open
US$25,64
High
US$26,10
Low
US$24,80
Mkt. cap
982,23 āšĨāŧ‰āšēāš™
Avg. vol.
555,72Â āšžāšąāš™
Volume
29,61Â āšžāšąāš™
52-wk high
US$37,48
52-wk low
US$4,71
EPS
US$-2,44
Shares outstanding
39,24 āšĨāŧ‰āšēāš™
No. of employees
68
News stories
From web sources and news partners
Investing.com Nigeria
Investing.com Nigeria
·
11 āšŠāšŧāŧˆāš§āŧ‚āšĄāš‡āšāŧˆāš­āš™
Form 4 Alto Neuroscience Inc For: 1 October By Investing.com
Investing.com
Investing.com
·
11 āšŠāšŧāŧˆāš§āŧ‚āšĄāš‡āšāŧˆāš­āš™
Alto Neuroscience president and CFO Smith sells $3.57m in shares
Stock Titan
Stock Titan
·
12 āšŠāšŧāŧˆāš§āŧ‚āšĄāš‡āšāŧˆāš­āš™
Exercising options at $2.35, Alto Neuroscience (ANRO)'s CFO sells shares.
TradingView
TradingView
·
12 āšŠāšŧāŧˆāš§āŧ‚āšĄāš‡āšāŧˆāš­āš™
Alto Neuroscience President And CFO Sold Shares Worth Over $3.5M
About Alto Neuroscience Inc
CEO-
Employees68
Founded2019
Headquarters-
SectorPharmaceutical industry
Analyst ratings
Based on 5 analysts giving stock ratings to ANRO in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for ANRO in the last 3 months.
Highest
Current US$25,03
US$55,00 (+119,74%)
Average
US$44,00 (+75,79%)
Lowest
US$37,00 (+47,82%)
Analyst
Recommendation
Action
Price target
Projected
Date
Patrick Trucchio
H.C. Wainwright
Buy
Maintained
US$55,00
+119,7%
09/21/2026
Tazeen Ahmad
Bank of America Securities
Buy
Maintained
-
-
08/14/2026
Andrew Tsai
Jefferies
Buy
Maintained
US$40,00
+59,8%
08/13/2026
Thomas Shrader
BTIG
Buy
Reiterated
US$37,00
+47,8%
08/13/2026
Myles Minter
William Blair
Buy
Reiterated
-
-
08/13/2026
Justin Walsh
JonesTrading
Buy
Reiterated
US$44,00
+75,8%
06/26/2026
Brian Skorney
Robert W. Baird
Buy
Maintained
US$36,00
+43,8%
05/18/2026
Laura Chico
Wedbush
Hold
Maintained
US$24,00
-4,1%
05/14/2026
Ritu Baral
TD Cowen
Buy
Maintained
-
-
05/13/2026
Keay Nakae
Chardan Capital
Buy
Maintained
US$30,00
+19,9%
04/21/2026
Paul Matteis
Stifel Nicolaus
Buy
Maintained
US$33,00
+31,8%
04/02/2026
Last report
12 āšŠ.āšŦ. 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
US$-0,65 / US$-0,77
+15,95%beat
Revenue / Est. (USD)
- / 0,00
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
āš.āš. 2025
āš—.āš§. 2025
āšĄ.āš™. 2026
āšĄāšī.āš–. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
10,52 āšĨāŧ‰āšēāš™
12,00 āšĨāŧ‰āšēāš™
20,29 āšĨāŧ‰āšēāš™
22,11 āšĨāŧ‰āšēāš™
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4,43 āšĨāŧ‰āšēāš™
5,06 āšĨāŧ‰āšēāš™
6,84 āšĨāŧ‰āšēāš™
7,02 āšĨāŧ‰āšēāš™
Operating expense
14,95 āšĨāŧ‰āšēāš™
17,06 āšĨāŧ‰āšēāš™
27,14 āšĨāŧ‰āšēāš™
29,13 āšĨāŧ‰āšēāš™
Total operating expenses
14,95 āšĨāŧ‰āšēāš™
17,06 āšĨāŧ‰āšēāš™
27,14 āšĨāŧ‰āšēāš™
29,13 āšĨāŧ‰āšēāš™
Operating income
-14,95 āšĨāŧ‰āšēāš™
-17,06 āšĨāŧ‰āšēāš™
-27,14 āšĨāŧ‰āšēāš™
-29,13 āšĨāŧ‰āšēāš™
Other non operating income
-112,00Â āšžāšąāš™
-113,00Â āšžāšąāš™
-115,00Â āšžāšąāš™
-130,00Â āšžāšąāš™
EBT including unusual items
-14,18 āšĨāŧ‰āšēāš™
-16,18 āšĨāŧ‰āšēāš™
-26,24 āšĨāŧ‰āšēāš™
-27,64 āšĨāŧ‰āšēāš™
EBT excluding unusual items
-14,18 āšĨāŧ‰āšēāš™
-16,18 āšĨāŧ‰āšēāš™
-26,24 āšĨāŧ‰āšēāš™
-27,64 āšĨāŧ‰āšēāš™
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-14,18 āšĨāŧ‰āšēāš™
-16,18 āšĨāŧ‰āšēāš™
-26,24 āšĨāŧ‰āšēāš™
-27,64 āšĨāŧ‰āšēāš™
Net profit margin
-
-
-
-
Earnings per share
-0,52
-0,45
-0,80
-0,65
Interest and investment income
1,53 āšĨāŧ‰āšēāš™
1,56 āšĨāŧ‰āšēāš™
1,56 āšĨāŧ‰āšēāš™
2,11 āšĨāŧ‰āšēāš™
Interest expense
-650,00Â āšžāšąāš™
-575,00Â āšžāšąāš™
-545,00Â āšžāšąāš™
-491,00Â āšžāšąāš™
Net interest expenses
882,00Â āšžāšąāš™
986,00Â āšžāšąāš™
1,02 āšĨāŧ‰āšēāš™
1,62 āšĨāŧ‰āšēāš™
Depreciation and amortization charges
-
-
-
-
EBITDA
-14,79 āšĨāŧ‰āšēāš™
-16,90 āšĨāŧ‰āšēāš™
-26,95 āšĨāŧ‰āšēāš™
-28,94 āšĨāŧ‰āšēāš™
Gain or loss from assets sale
114,00Â āšžāšąāš™
-
9,00Â āšžāšąāš™
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
āŧāš­āšąāššāš‚āš­āš‡ Google